Regulatory & Compliance

Deviation Management.

Identify, evaluate, and permanently resolve deviations. We develop robust deviation management systems in accordance with GMP standards.

Quality team during deviation investigation

Why is deviation management more than just mandatory documentation?

Deviation management is a central component of GMP and QMS—and often determines approvals and product risks:

  • Deviations that are not recorded or are incompletely documented are the most common findings during GMP inspections.
  • Failure to conduct a systematic root-cause analysis leads to the immediate recurrence of the same deviations.
  • A backlog of unresolved deviations jeopardizes batch releases and marketing authorizations.
  • Out-of-specification (OOS) results without a structured testing process pose a significant risk of FDA action.
Are all deviations in your production fully recorded and evaluated in a timely manner?
The quality officer documents the root cause findings of a deviation report

Our deviation management services.

We provide clarity, structure, and absolute process reliability in deviation handling.

Deviation System Design & SOP
Establishment of a comprehensive deviation process: recording, initial assessment, root cause analysis, initiation of CAPA, and documentation. Includes GMP-compliant SOPs and forms.
OOS Investigation Process
Implementation of an Out-of-Specification (OOS) investigation procedure compliant with FDA and EU GMP: Phase 1 (laboratory error), Phase 2 (production-related cause), and Phase 3 (batch disposition).
Deviation Backlog Cleanup
Structured review of historical deviations: prioritization, risk assessment, completion of missing documentation, and systematic development of CAPA actions prior to inspections.
Training & Process Integration
Training production staff and QA teams in proper deviation handling: timely reporting, accurate initial assessment, documentation, and timely escalation.

From real-world experience: Out-of-specification (OOS) handling and deviation review.

An international active pharmaceutical ingredient manufacturer was faced with frequent out-of-specification (OOS) results and an unclear process for managing deviations.

The challenge

Recurring OOS incidents are blocking approvals.

Due to inadequate Phase 1 testing in the QC laboratory, out-of-specification results were directly classified as production defects (deviations). This led to over 80 unjustified, blocking deviations and significant delays in batch release.

Measures

Restructuring of Phase 1 and Phase 2 studies.

Entourage implemented a strict separation: first, an analytical investigation checklist (Phase 1) for the laboratory. Only after the OOS result was confirmed was the comprehensive deviation and root cause analysis (Phase 2) initiated in the production area.

Results

60% fewer deviations, reliable batch release.

Thanks to clear definitions and a structured approach, the number of unjustified production deviations was reduced by 60%. The time required to address actual deviations was cut in half through targeted root-cause analyses.

Why Entourage for Deviation Management.

Effective deviation management not only addresses symptoms but also strengthens the entire organization.

Comprehensive compliance assurance.

We understand the exact requirements of the FDA, EMA, and Notified Bodies regarding deviation reports and ensure that your documentation stands up to any audit.

Operational relief (hands-on).

An overburdened QA team makes mistakes. We actively take on the task of addressing critical backlogs and writing root-cause reports to ensure your production environment remains operational.

Expertise in OOS/OOT.

Results that are out of specification or out of trend require highly specialized analytical and manufacturing investigations. Our experts are skilled in both areas.

Seamless QMS integration.

A deviation should never stand alone. We ensure that your deviations are properly linked to CAPA, complaint, and change control processes.

This is how we work.

The structured 4-phase process for legally compliant deviation management.

01

Triage & Initial Assessment.

Immediate reporting of the incident (within 24 hours), classification of severity (Minor, Major, Critical), and initiation of immediate risk mitigation measures.

02

Investigation & Root Cause Analysis.

In-depth root-cause analysis involving production, the laboratory, and quality assurance to avoid merely treating symptoms.

03

CAPA derivation.

Development of specific corrective and preventive actions that are directly derived from and prioritized based on the identified root cause.

04

Closure & Trends.

Verification of the documentation for completeness, formal closure of the deviation, and inclusion in the regular quality trending (Management Review).

Frequently Asked Questions About Deviation Management.

What is a deviation in GMP manufacturing?
A deviation is any unintended departure from an approved specification, method, SOP, or manufacturing parameter. It must be immediately recorded, assessed (minor, major, critical), and documented—regardless of whether a finished product is directly affected.
What is the difference between a deviation and a CAPA?
A deviation is the event itself: the identified discrepancy. A CAPA is the planned response: corrective action (to rectify the error) and preventive action (to prevent recurrence). CAPAs are triggered by deviations, but they are independent follow-up steps within the QMS.
What is an OOS result, and how is it interpreted?
OOS (Out-of-Specification) refers to an analytical result that falls outside the established specifications. FDA guidelines and EU GMP require a two-phase investigation process: first, the definitive exclusion of laboratory errors (Phase 1), followed by an in-depth investigation of product and process causes (Phase 2).
How should a deviation backlog be addressed?
By systematically prioritizing based on severity and regulatory risk: critical deviations with batch relevance first, followed by major deviations, and finally minor deviations. When dealing with large backlogs, the safest approach ahead of an audit is to temporarily deploy task forces and external compliance support (such as ENTOURAGE).

Additional expertise in the area of Quality & Compliance.

Expertise

CAPA Management

Effectively implement and track corrective and preventive actions following deviations.

 Expertise

Complaint Management

Investigate customer-initiated complaints, report them to the authorities, and manage them as deviations.

 Expertise

GMP Consulting

Ensuring compliance with GMP principles in production, the laboratory, and the supply chain.

Resolve deviation backlogs – Gain audit assurance.

Whether you need to restructure your investigation process, provide OOS training for your teams, or require immediate hands-on support to reduce a deviation backlog, we bring the necessary technical and methodological expertise directly to you.

Submit a project inquiry.

Please briefly describe your current challenge. An expert from our team will contact you shortly.